Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Merus | Fierce Biotech
Genmab to Acquire Merus in $8 Billion Biotech Deal - USA Herald
Darwin's Our Take: Genmab agrees to acquire Dutch biotech Merus for $8 ...
Oncologie : Genmab s’offre la biotech Merus pour 8 Mrds
Genmab agrees $8bn takeover of cancer biotech Merus | pharmaphorum
Merus N.V. (MRUS): The Biotech Stock with Biggest Upside Potential
Genmab neemt de Nederlandse biotech Merus over in een deal van $ 8 ...
Genmab to buy Dutch biotech firm Merus for €6.8 billion - DutchNews.nl
Genmab's USD 8.0 Billion Merus Acquisition: A Strategic Move in Biotech ...
Genmab Buys Rising Cancer Star Merus for $8B – Biotech Insider
Genmab acquires Merus for $8bn, shaping biotech M&A and antibody ...
Genmab to buy cancer biotech Merus for $8B
Genmab Buys Rising Cancer Star Merus for $8B - Biotech Today
BIOTECH (116) Merus NV: Multispecific T Cell Engagers – BOSTON DR LIM
Incyte in $200M-plus Merus research deal, shares jump | Fierce Biotech
Merus | Krystal Biotech
Genmab agrees $8bn takeover of cancer biotech Merus - NEWS - 29.09.25
European cancer biotech Merus nabs Sanofi I-O chief Andrew Joe ...
Merus and UEC surge as stock market gainers on biotech and nuclear bets ...
Merus grabs first-in-class US approval for NRG1 cancer drug | pharmaphorum
Merus announces First Patient Dosed in Phase 2 Trial of
Merus Announces Publication of an Abstract on Petosemtamab in ...
Merus Labs Scooped Up By This European Pharma In $342 Million Deal ...
Genmab swallows Merus in US$8bn deal - European Biotechnology Magazine
Publications | Merus
Red Biotech (Biopharma) - EconSight
Merus logo hi-res stock photography and images - Alamy
About Merus - Merus
Merus advances the world's first LGR5-targeted bispecific antibody into ...
Merus - AnnualReports.com
Genmab after Merus acquisition - EconSight
Biotech And Pharma Stock News | Investor's Business Daily
Merus Unveils New Logo and Brand Identity
Merus (MRUS) Stock Price & Overview
Merus (MRUS): A Breakthrough in Oncology with Phase 2 Triumph and ...
Genmab to Acquire Merus for $8 Billion, Expanding Cancer Drug Pipeline ...
Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer ...
Merus - Accelerator Utrecht - STONE22
Merus receives FDA accelerated approval to treat NRG1+ cancers
Merus N.V. (MRUS): A Deep Dive into the Cancer-Focused Biotech's Recent ...
Merus NV: Biotech-Hoffnung mit Kursrally – wie viel Potenzial steckt ...
Genmab-Merus Acquisition: Biotech Giants Poised for Major M&A Deal
Petosemtamab secures a buyout for Merus | ApexOnco - Clinical Trials ...
Genmab's Strategic Gambit: Assessing the Merus Acquisition's Value in ...
Merus announces First Patient Dosed in Phase 2 Trial of Petosemtamab in ...
Strategic Value Creation in Biotech: Genmab's Potential Merus ...
Genmab's $8 Billion Merus Acquisition: A Strategic Masterstroke in ...
90 V Biotech Logo Royalty-Free Images, Stock Photos & Pictures ...
Early Merus drug data show survival boost in head and neck cancer | STAT
Gilead tries new triple-target T-cell engagers in $1.5B-plus Merus ...
Insmed, Merus announce public offerings; AI startup raises $13M seed ...
Norgine to acquire Merus - European Biotechnology Magazine
Video: Genmab to acquire Merus for $8B cash, adding Phase 3 ...
Merus cancer bispecific lives up to investors' expectations
Genmab’s $8 Billion Acquisition of Merus Shakes Up Biotech...
IRB Barcelona and Merus form a research collaboration to develop ...
Static Var Compensator - Merus® SVC - Merus Power
Pfizer adds ex-State Street CEO to the board; Two Merus execs head for ...
Merus shares dip as interim lung cancer data reveal 3 patient deaths ...
Merus Announces Business Update Conference Call - Merus | The Antibody ...
Improvements in O&G Industry Using Merus Technology | PDF | Oil ...
Merus Buyout Rumor Gets Retail Traders Buzzing — Genmab Said To Be ...
Genmab to buy Dutch cancer drugmaker Merus for $8 billion - The ...
Merus drug and Keytruda shrank tumors in patients with head and neck cancer
Lilly links up with Merus on CD3-engaging bispecific antibodies ...
Active Harmonic Filter - Merus® A2 - Merus Power
Biotech-bedrijven op Utrecht Science Park Genmab en Merus bundelen ...
Merus | 'Butterfly babies' may find help with Krystal Biotech's…
Merus N.V. (MRUS): A Breakthrough in Oncology with Petosemtamab's ASCO ...
Genmab Announces $5.2 Billion Acquisition of Merus to Expand Late-Stage ...
Merus Stock Skyrockets On 'Unprecedented' Results In Head-And-Neck ...
Merus and Halozyme Enter Global Collaboration and License Agreement to ...
MERUS MEXICO SOLUTIONS SA DE CV | LinkedIn
Merus' NRG1+ drug responses edge up in tough pancreatic cancer
Germany. 07th June, 2025. In this photo illustration, a person is ...
2 Bill Lundberg Royalty-Free Images, Stock Photos & Pictures | Shutterstock
A first for Merus’ Bizengri with FDA nod | The Pharmaletter
Genmab schluckt Merus: Biotech-Übernahmewelle rollt › sharedeals.de
Funding the Next Generation of Cancer Therapies
Merus: Riding The Bispecific Wave In Oncology (NASDAQ:MRUS) | Seeking Alpha
Merus: Dutch Drug Developer With Interesting Platform (NASDAQ:MRUS ...
Eli Lilly-Merus's pact; Vera bags $80M; Covid-19 pipeline; AML research
80亿美元！Genmab官宣收购Merus医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Slide 20
Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating ...
Merus: Changes in management - European Biotechnology Magazine
先声药业官网
80亿美元！Genmab官宣收购双抗公司Merus医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Merus’ Petosemtamab Interim Data Demonstrates Clinically Meaningful ...
_ecec9c771759151261554.jpeg)
